Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. (Q54576533)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. |
scientific article |
Statements
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. (English)
1 reference
John D Hainsworth
1 reference
Denise A Yardley
1 reference
Eric Raefsky
1 reference
Raul Castillo
1 reference
Anup Lahiry
1 reference
Richard Locicero
1 reference
Dana Thompson
1 reference
Mythili Shastry
1 reference
Howard A Burris
1 reference
5 May 2011
1 reference
11
1 reference
5
1 reference
297-305
1 reference
Identifiers
1 reference